News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,719 Results
Type
Article (15153)
Company Profile (298)
Press Release (271260)
Multimedia
Podcasts (93)
Webinars (12)
Section
Business (80156)
Career Advice (166)
Deals (13421)
Drug Delivery (43)
Drug Development (50795)
Employer Resources (31)
FDA (5927)
Job Trends (5195)
News (145643)
Policy (10112)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (937)
Accelerated approval (25)
Adcomms (14)
Allergies (97)
Alliances (21795)
ALS (153)
Alzheimer's disease (1104)
Antibody-drug conjugate (ADC) (349)
Approvals (6179)
Artificial intelligence (332)
Autoimmune disease (199)
Automation (10)
Bankruptcy (105)
Best Places to Work (4568)
BIOSECURE Act (6)
Biosimilars (115)
Biotechnology (230)
Bladder cancer (117)
Brain cancer (55)
Breast cancer (394)
Cancer (3723)
Cardiovascular disease (274)
Career advice (151)
Career pathing (8)
CAR-T (253)
CDC (6)
Cell therapy (660)
Cervical cancer (21)
Clinical research (44462)
Collaboration (1380)
Company closure (2)
Compensation (697)
Complete response letters (54)
COVID-19 (1117)
CRISPR (100)
C-suite (700)
Cystic fibrosis (117)
Data (5224)
Denatured (19)
Depression (108)
Dermatology (42)
Diabetes (290)
Diagnostics (1426)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (240)
Drug pricing (51)
Drug shortages (3)
Duchenne muscular dystrophy (259)
Earnings (32417)
Editorial (31)
Employer branding (4)
Employer resources (29)
Events (52880)
Executive appointments (669)
FDA (7982)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (13)
Frontotemporal dementia (30)
Funding (1134)
Gene editing (213)
Generative AI (29)
Gene therapy (570)
GLP-1 (545)
Government (1180)
Grass and pollen (3)
Guidances (174)
Healthcare (6679)
HIV (26)
Huntington's disease (48)
IgA nephropathy (80)
Immunology and inflammation (222)
Immuno-oncology (67)
Indications (116)
Infectious disease (1260)
Inflammatory bowel disease (170)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (191)
Interviews (19)
IPO (7364)
IRA (13)
Job creations (872)
Job search strategy (131)
JPM (41)
Kidney cancer (9)
Labor market (26)
Layoffs (249)
Leadership (11)
Legal (1412)
Liver cancer (44)
Longevity (22)
Lung cancer (494)
Lymphoma (280)
Machine learning (32)
Management (7)
Manufacturing (465)
MASH (145)
Medical device (2742)
Medtech (2753)
Mergers & acquisitions (6753)
Metabolic disorders (836)
mRNA (144)
Multiple sclerosis (118)
NASH (14)
Neurodegenerative disease (291)
Neuropsychiatric disorders (79)
Neuroscience (2187)
Neurotech (1)
NextGen: Class of 2026 (2066)
Non-profit (873)
Now hiring (38)
Obesity (379)
Opinion (136)
Ovarian cancer (162)
Pain (125)
Pancreatic cancer (201)
Parkinson's disease (279)
Partnered (12)
Patents (362)
Patient recruitment (451)
Peanut (46)
People (27066)
Pharmaceutical (42)
Pharmacy benefit managers (6)
Phase 1 (15757)
Phase 2 (20687)
Phase 3 (13039)
Pipeline (4974)
Policy (101)
Postmarket research (853)
Preclinical (6694)
Press Release (30)
Prostate cancer (179)
Psychedelics (56)
Radiopharmaceuticals (269)
Rare diseases (809)
Real estate (1464)
Recruiting (12)
Regulatory (10378)
Reports (20)
Research institute (980)
Resumes & cover letters (20)
Rett syndrome (32)
RNA editing (25)
RSV (24)
Schizophrenia (141)
Series A (222)
Series B (153)
Service/supplier (1)
Sickle cell disease (89)
Special edition (19)
Spinal muscular atrophy (124)
Sponsored (17)
Startups (2026)
State (1)
Stomach cancer (5)
Supply chain (38)
Tariffs (19)
The Weekly (72)
Vaccines (381)
Venture capital (81)
Weight loss (203)
Women's health (40)
Worklife (2)
Date
Today (88)
Last 7 days (417)
Last 30 days (1637)
Last 365 days (18015)
2026 (5957)
2025 (18123)
2024 (20564)
2023 (22434)
2022 (26863)
2021 (27852)
2020 (23404)
2019 (16282)
2018 (11773)
2017 (13777)
2016 (11875)
2015 (14398)
2014 (10417)
2013 (7532)
2012 (7590)
2011 (7678)
2010 (7474)
Location
Africa (154)
Alabama (71)
Alaska (2)
Arizona (82)
Arkansas (6)
Asia (18547)
Australia (3175)
California (8044)
Canada (2078)
China (924)
Colorado (287)
Connecticut (300)
Delaware (276)
Europe (39851)
Florida (1025)
Georgia (236)
Hawaii (2)
Idaho (17)
Illinois (469)
India (43)
Indiana (188)
Iowa (8)
Japan (276)
Kansas (82)
Kentucky (11)
Louisiana (12)
Maine (12)
Maryland (830)
Massachusetts (6334)
Michigan (122)
Minnesota (282)
Mississippi (3)
Missouri (35)
Montana (17)
Nebraska (6)
Nevada (43)
New Hampshire (22)
New Jersey (1850)
New Mexico (13)
New York (1996)
North Carolina (932)
North Dakota (6)
Northern California (4055)
Ohio (202)
Oklahoma (11)
Oregon (23)
Pennsylvania (1473)
Puerto Rico (11)
Rhode Island (27)
South America (218)
South Carolina (12)
Southern California (3198)
Tennessee (48)
Texas (1070)
United States (26518)
Utah (108)
Virginia (167)
Washington D.C. (37)
Washington State (661)
West Virginia (1)
Wisconsin (51)
286,719 Results for "blade therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sound Blade Medical Appoints Neil Barman, M.D. as Chief Executive Officer
August 1, 2025
·
2 min read
BioMidwest
Journal of Craniofacial Surgery Study Proves Planatome Blades Reduce Tissue Damage and Improve Diabetic Wound Healing from Surgical Incisions Test subjects showed less inflammation and faster healing from using nano-polished blades
Planatome, a medical device company that applies atomic-level polishing from the semiconductor industry to create advanced surgical blades that lead to better patient outcomes, announced a new study published in the Journal of Craniofacial Surgery.
April 18, 2024
·
4 min read
Press Releases
Sound Blade Medical Closes $16.5 Million Series A Financing to Advance the Development of Innovative Handheld Histotripsy Therapy
January 30, 2025
·
2 min read
Business
Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement
Biotech Acquisition Company (NASDAQ: BIOT) (“BAC”), a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. (“Blade”), a biopharmaceutical company based in South San Francisco, Calif., today announced that they have mutually agreed to terminate the previously announced Agreement and Plan of Merger (the “Merger Agreement”), effective immediately.
June 13, 2022
·
7 min read
Biotech Bay
Blade Therapeutics to Participate in Upcoming Investor Conferences - Mar 07, 2022
Blade Therapeutics, Inc. announced that Wendye Robbins, M.D., president and CEO, will present at two investor conferences in March.
March 7, 2022
·
12 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston
April 27, 2026
·
6 min read
Press Releases
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
February 23, 2026
·
3 min read
Deals
Blade Therapeutics Eyes Nasdaq in 2022 with Planned SPAC Merger
The merger between Blade Therapeutics and Biotech Acquisition Company will provide the company with $254.3 million to drive the development of cudetaxestat.
November 8, 2021
·
3 min read
·
Alex Keown
Business
Blade Therapeutics Mourns the Passing of General Counsel and Secretary Alan C. Mendelson
Blade Therapeutics, Inc. (Blade) today announced with profound sadness the unexpected passing of company General Counsel and Secretary Alan C. Mendelson on October 8, 2021, in San Francisco.
October 11, 2021
·
2 min read
1 of 28,672
Next
